474 related articles for article (PubMed ID: 28412995)
41. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.
Thangaratinam S; Ismail KM; Sharp S; Coomarasamy A; Khan KS;
BJOG; 2006 Apr; 113(4):369-78. PubMed ID: 16553648
[TBL] [Abstract][Full Text] [Related]
42. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.
Payne B; Hodgson S; Hutcheon JA; Joseph KS; Li J; Lee T; Magee LA; Qu Z; von Dadelszen P;
BJOG; 2013 Jan; 120(1):113-8. PubMed ID: 23078362
[TBL] [Abstract][Full Text] [Related]
43. Prediction of pre-eclampsia at St. Mary's hospital lacor, a low-resource setting in northern Uganda, a prospective cohort study.
Awor S; Abola B; Byanyima R; Orach CG; Kiondo P; Kaye DK; Ogwal-Okeng J; Nakimuli A
BMC Pregnancy Childbirth; 2023 Feb; 23(1):101. PubMed ID: 36755228
[TBL] [Abstract][Full Text] [Related]
44. Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in women with gestational diabetes: The PeRSonal GDM model.
Cooray SD; Boyle JA; Soldatos G; Allotey J; Wang H; Fernandez-Felix BM; Zamora J; Thangaratinam S; Teede HJ
EClinicalMedicine; 2022 Oct; 52():101637. PubMed ID: 36313142
[TBL] [Abstract][Full Text] [Related]
45. Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women.
Irion O; Massé J; Forest JC; Moutquin JM
Br J Obstet Gynaecol; 1998 Apr; 105(4):422-9. PubMed ID: 9609270
[TBL] [Abstract][Full Text] [Related]
46. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial.
García B; Llurba E; Valle L; Gómez-Roig MD; Juan M; Pérez-Matos C; Fernández M; García-Hernández JA; Alijotas-Reig J; Higueras MT; Calero I; Goya M; Pérez-Hoyos S; Carreras E; Cabero L
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):680-9. PubMed ID: 26823208
[TBL] [Abstract][Full Text] [Related]
47. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
48. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia.
Plasencia W; Maiz N; Poon L; Yu C; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Aug; 32(2):138-46. PubMed ID: 18634131
[TBL] [Abstract][Full Text] [Related]
49. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
[TBL] [Abstract][Full Text] [Related]
50. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
[TBL] [Abstract][Full Text] [Related]
51. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
[TBL] [Abstract][Full Text] [Related]
52. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
[TBL] [Abstract][Full Text] [Related]
53. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
[TBL] [Abstract][Full Text] [Related]
54. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure.
Onwudiwe N; Yu CK; Poon LC; Spiliopoulos I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Dec; 32(7):877-83. PubMed ID: 18991324
[TBL] [Abstract][Full Text] [Related]
55. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women.
Velauthar L; Plana MN; Kalidindi M; Zamora J; Thilaganathan B; Illanes SE; Khan KS; Aquilina J; Thangaratinam S
Ultrasound Obstet Gynecol; 2014 May; 43(5):500-7. PubMed ID: 24339044
[TBL] [Abstract][Full Text] [Related]
56. Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.
Elia EG; Robb AO; Hemming K; Price MJ; Riley RD; French-Constant A; Denison FC; Kilby MD; Morris RK; Stock SJ
Acta Obstet Gynecol Scand; 2017 May; 96(5):580-588. PubMed ID: 28247485
[TBL] [Abstract][Full Text] [Related]
57. Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation.
Andrietti S; Silva M; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jul; 48(1):72-9. PubMed ID: 26566592
[TBL] [Abstract][Full Text] [Related]
58. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre-eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study.
Brunelli E; Seidenari A; Germano C; Prefumo F; Cavoretto P; Di Martino D; Masturzo B; Morano D; Rizzo N; Farina A
BJOG; 2020 Sep; 127(10):1210-1215. PubMed ID: 32275798
[TBL] [Abstract][Full Text] [Related]
59. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.
Papageorghiou AT; Yu CK; Bindra R; Pandis G; Nicolaides KH;
Ultrasound Obstet Gynecol; 2001 Nov; 18(5):441-9. PubMed ID: 11844162
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
